Pursuant to the provision of Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, Biofil Chemicals & Pharmaceuticals has informed that Company has received intimation from its Registrar & Share Transfer Agent on 6th July, 2022 regarding loss of Share Certificate(s) by respective shareholder. Pursuant to SEBI Circular Number SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated 25th January, 2022 a letter of confirmation will be issued to the shareholders only after the receipt of all necessary documents and compliance of required formalities.
The above information is a part of company’s filings submitted to BSE.
